tiprankstipranks
Reliance Global Group (EZRA)
NASDAQ:EZRA
US Market
Want to see EZRA full AI Analyst Report?

Reliance Global Group (EZRA) AI Stock Analysis

474 Followers

Top Page

EZRA

Reliance Global Group

(NASDAQ:EZRA)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
$3.50
▲(493.22% Upside)
Action:Reiterated
Date:06/06/26
The score is held down primarily by weak financial performance (persistent losses and negative operating/free cash flow with recent revenue softness) and bearish technicals (price below all key moving averages with negative MACD). Corporate events provide some support via regained Nasdaq compliance and strategic/product updates, but potential dilution actions and a loss-making valuation profile limit the upside.
Positive Factors
Nasdaq compliance restored
Restoring Nasdaq minimum bid compliance removes a material listing overhang and preserves access to public capital markets. That stability supports longer-term financing optionality and investor confidence, reducing existential listing risk and enabling multi-quarter strategic execution and partnership development.
Negative Factors
Persistent negative cash flow
Continued negative operating and free cash flow across reporting periods signals structural cash-generation weakness. Accelerating cash burn increases reliance on external financing and equity issuances, limiting ability to self-fund growth, raising dilution risk and constraining multi-quarter investment capacity.
Read all positive and negative factors
Positive Factors
Negative Factors
Nasdaq compliance restored
Restoring Nasdaq minimum bid compliance removes a material listing overhang and preserves access to public capital markets. That stability supports longer-term financing optionality and investor confidence, reducing existential listing risk and enabling multi-quarter strategic execution and partnership development.
Read all positive factors

Reliance Global Group (EZRA) vs. SPDR S&P 500 ETF (SPY)

Reliance Global Group Business Overview & Revenue Model

Company Description
Reliance Global Group, Inc. is a diversified company, which engages in the business of insurance market and other relates sectors. It focuses on acquisition strategy, wholesale, and retail insurance agencies. The company was founded on August 2, 2...
How the Company Makes Money
Reliance Global Group generally earns revenue through insurance distribution economics associated with agency and brokerage operations. The core revenue stream is commissions and fees generated when the company (or its agents) places insurance pol...

Reliance Global Group Earnings Call Summary

Earnings Call Date:Mar 10, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Aug 18, 2026
Earnings Call Sentiment Neutral
The call described a clear strategic pivot and tangible balance sheet improvements (cash, working capital, equity), meaningful growth in the RELI Exchange distribution network and early-stage technology investments that could deliver long-term upside. Offsetting these positives are a decline in commission income after divestitures, a wider adjusted EBITDA loss, continued net losses, rising operating costs driven by equity-based compensation, and limited unrestricted cash. Technology investments are promising but remain milestone-dependent and speculative in the near term.
Positive Updates
Balance Sheet Improvements
Unrestricted cash increased to $1.3M (reported +$0.9M or +250% YoY). Working capital improved to $1.9M (reported +$1.5M or +351% YoY). Stockholders' equity increased to $6.4M (reported +$3.4M or +114% YoY). Management also reported reduced long-term debt and greater financial flexibility following portfolio realignment.
Negative Updates
Commission Income Decline Following Divestitures
Commission income decreased to $12.4M from $14.1M in 2024 (decline of $1.7M, approx -12%), primarily reflecting strategic divestitures during the year.
Read all updates
Q4-2025 Updates
Negative
Balance Sheet Improvements
Unrestricted cash increased to $1.3M (reported +$0.9M or +250% YoY). Working capital improved to $1.9M (reported +$1.5M or +351% YoY). Stockholders' equity increased to $6.4M (reported +$3.4M or +114% YoY). Management also reported reduced long-term debt and greater financial flexibility following portfolio realignment.
Read all positive updates
Company Guidance
Management's guidance centers on executing the Scale51 strategy over the next 6–12 months with milestone-based investments (aiming for near-term revenue from Enquantum, potentially later this year) while relying on the insurance/InsurTech core that produced $12.4M in commission income in 2025 (vs. $14.1M in 2024); they highlighted 36% YoY growth in personal P&C premiums, a ~72% increase in policies written during the most recent health open enrollment, and expansion of the RELI Exchange partner network from ~65 to ~250 agencies since 2022; financial moves to support this plan include a $5.0M cash sale of Fortman, unrestricted cash up $0.9M to $1.3M (+250%), working capital up $1.5M to $1.9M (+351%), stockholders’ equity up $3.4M to $6.4M (+114%), commission expense of $4.6M, salaries and wages of $10.3M, G&A of $4.9M, a net loss improved to $7.0M (from $9.1M), and an adjusted EBITDA loss of $1.6M (from $0.3M), with management expecting these actions to strengthen liquidity, simplify operations and position Reliance/EZRA for disciplined, technology-driven growth.

Reliance Global Group Financial Statement Overview

Summary
Overall fundamentals are weak: revenue has been flat-to-down recently, profitability is consistently poor with large net losses and very negative margins, and operating/free cash flow are negative across all periods (with cash burn accelerating in TTM). The main offset is improved leverage and positive, improving equity, but ongoing losses and cash burn remain the dominant risk.
Income Statement
18
Very Negative
Balance Sheet
46
Neutral
Cash Flow
14
Very Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue11.10M12.43M14.05M13.73M11.76M9.71M
Gross Profit-536.96K0.002.64M2.50M1.11M2.61M
EBITDA-7.57M-7.68M-5.70M-5.76M25.04M-1.31M
Net Income-6.72M-6.99M-9.07M-12.01M6.47M-21.10M
Balance Sheet
Total Assets13.79M13.55M17.32M23.02M38.43M27.68M
Cash, Cash Equivalents and Short-Term Investments2.27M1.32M372.69K1.33M505.41K4.14M
Total Debt1.52M2.26M13.03M14.54M17.57M9.43M
Total Liabilities6.37M7.12M14.32M15.87M29.52M53.74M
Stockholders Equity7.42M6.43M3.00M7.15M8.91M-26.07M
Cash Flow
Free Cash Flow-6.32M-3.11M-2.60M-1.04M-3.99M-2.94M
Operating Cash Flow-6.30M-3.09M-2.52M-847.97K-3.19M-2.25M
Investing Cash Flow4.83M5.33M-83.23K710.19K-24.64M-2.30M
Financing Cash Flow673.65K-1.30M1.66M966.92K25.12M8.64M

Reliance Global Group Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.59
Price Trends
50DMA
6.19
Negative
100DMA
8.27
Negative
200DMA
19.71
Negative
Market Momentum
MACD
-0.81
Negative
RSI
28.93
Positive
STOCH
13.41
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EZRA, the sentiment is Negative. The current price of 0.59 is below the 20-day moving average (MA) of 4.46, below the 50-day MA of 6.19, and below the 200-day MA of 19.71, indicating a bearish trend. The MACD of -0.81 indicates Negative momentum. The RSI at 28.93 is Positive, neither overbought nor oversold. The STOCH value of 13.41 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EZRA.

Reliance Global Group Risk Analysis

Reliance Global Group disclosed 38 risk factors in its most recent earnings report. Reliance Global Group reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Reliance Global Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
60
Neutral
$14.56M-8.354.56%19.30%-17.56%
57
Neutral
$50.15M1.603.57%-4.28%-1.93%
43
Neutral
$2.08M-0.22-113.59%-15.39%73.24%
41
Neutral
$22.29M-2.29-404.40%37.29%-396.13%
40
Underperform
$21.39M-0.04-135.15%-81.69%-9884.70%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EZRA
Reliance Global Group
3.56
-53.48
-93.77%
EHTH
Ehealth
1.73
-2.57
-59.77%
HUIZ
Huize Holding
1.40
-0.63
-31.03%
GOCO
GoHealth
0.67
-5.48
-89.04%
ZBAO
Zhibao Technology Inc. Class A
0.67
-0.34
-33.99%

Reliance Global Group Corporate Events

Business Operations and StrategyDelistings and Listing ChangesRegulatory Filings and Compliance
Reliance Global Group Regains Nasdaq Minimum Bid Compliance
Positive
Jun 3, 2026
On June 3, 2026, Reliance Global Group announced it had regained compliance with Nasdaq’s minimum bid price requirement after its stock closed at or above $1.00 for 10 consecutive business days from May 18 through June 1, 2026. This followed...
Delistings and Listing ChangesRegulatory Filings and ComplianceStock Split
Reliance Global Group Announces 1-for-40 Reverse Stock Split
Neutral
May 14, 2026
Reliance Global Group, Inc., a Nasdaq-listed InsurTech company, leverages AI-driven platforms to serve both independent insurance agencies and retail consumers, and also operates a strategic growth arm targeting high-growth technology companies. I...
Business Operations and StrategyExecutive/Board ChangesPrivate Placements and FinancingShareholder Meetings
Reliance Global Shareholders Approve Governance and Equity Measures
Positive
May 7, 2026
On May 6, 2026, Reliance Global Group, Inc. held its 2026 annual meeting of stockholders via webcast, with 45.13% of eligible shares represented, and stockholders elected five directors to serve until the 2027 annual meeting. Investors also ratifi...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Reliance Global Group Expands Into Radiopharmaceuticals with Investment
Positive
May 4, 2026
Reliance Global Group has formed LifeSci Global Group LLC as a majority-owned vehicle to invest in healthcare and early-stage life sciences companies, funding its deals via loans from the company and its subsidiary EIG. The move extends Reliance&#...
Business Operations and StrategyProduct-Related Announcements
Reliance Global Unveils RELI Exchange 2.0 InsurTech Upgrade
Positive
Mar 27, 2026
On March 25, 2026, Reliance Global Group launched RELI Exchange 2.0, an upgraded version of its InsurTech platform for independent insurance agencies, aimed at expanding recruiting capacity and improving execution. The move follows strong momentum...
Business Operations and StrategyLegal ProceedingsPrivate Placements and FinancingRegulatory Filings and Compliance
Reliance Global Restates Governance and Extends Capital Commitment
Positive
Mar 17, 2026
On March 13 and March 11, 2026, Reliance Global Group, Inc. entered into two settlement agreements resolving disputes tied to prior stock purchase transactions, under which investors had acquired 1,333,334 common shares each for $100,000 and alleg...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 06, 2026